Source link : https://newshealth.biz/health-news/combo-therapy-boosts-survival-in-resectable-biliary-tract-cancer/
(MedPage Today) — Camrelizumab, an investigational immunotherapy, on top of adjuvant capecitabine (Xeloda) and radiotherapy, improved survival outcomes in patients with resectable biliary tract cancers (extrahepatic cholangiocarcinoma [EHC] and… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116452 Author : Publish date : 2025-07-10 17:25:00 Copyright for syndicated content belongs to the linked Source.
The post Combo Therapy Boosts Survival in Resectable Biliary Tract Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-10 17:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8